Moreover, breast cancer patients who are positive for BNIP3 expression exhibit lower rates of axillary lymph node metastasis [56], while high expression of BNIP3 in node-negative breast cancer patients is associated with a worse prognosis [57]. Here, BNIP3 is linked to metastatic malignant neoplasm in the lymph nodes.